- Coordinates
- PDB Format
- Method
- ELECTRON CRYSTALLOGRAPHY 2.00 Å
- Oligo State
- monomer
- Ligands
- 1 x ZMA: 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol(Non-covalent)
- 3 x CLR: CHOLESTEROL(Non-covalent)
CLR.2: 12 residues within 4Å:- Chain A: L.83, F.87, F.95, A.97, A.98, G.101, C.102, F.104, I.105, Q.188
- Ligands: OLC.21, OLC.25
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.83, A:F.87, A:F.87, A:F.95, A:A.97, A:A.98, A:F.104, A:I.105, A:I.105
- Hydrogen bonds: A:A.98, A:Q.188
CLR.3: 13 residues within 4Å:- Chain A: L.365, L.368, P.369, I.372, I.373, F.376, C.383, S.384, H.385, A.386, P.387, L.390
- Ligands: OLA.6
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.368, A:P.369, A:I.373, A:L.390
- Hydrogen bonds: A:S.384
CLR.4: 11 residues within 4Å:- Chain A: F.207, F.208, L.212, L.368, I.372, C.375, F.376, F.379, C.380, C.383
- Ligands: OLC.24
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:F.207, A:F.208, A:L.212, A:L.368, A:F.376, A:F.376, A:F.376, A:F.379, A:F.379
- 15 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.5: 11 residues within 4Å:- Chain A: L.39, V.82, P.86, I.89, T.90, T.93, F.95
- Ligands: OLA.7, OLA.8, OLA.18, OLC.21
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:T.90
OLA.6: 7 residues within 4Å:- Chain A: S.384, A.386, P.387, W.389, L.390, L.393
- Ligands: CLR.3
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.389, A:L.390, A:L.390
OLA.7: 6 residues within 4Å:- Chain A: I.35, L.39, I.89
- Ligands: OLA.5, OLA.9, OLA.18
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.35, A:L.39
OLA.8: 3 residues within 4Å:- Ligands: OLA.5, OLA.18, OLC.21
No protein-ligand interaction detected (PLIP)OLA.9: 6 residues within 4Å:- Chain A: S.32, I.35, T.36, L.39, A.40
- Ligands: OLA.7
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.35, A:T.36
OLA.10: 10 residues within 4Å:- Chain A: F.69, F.118, L.121, A.122, I.125, D.126, I.129, V.141, I.149, C.153
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:A.122, A:I.125, A:I.149, A:I.149
- Hydrogen bonds: A:D.126
OLA.11: 3 residues within 4Å:- Chain A: W.389, L.393
- Ligands: OLA.15
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.389, A:W.389, A:W.389
OLA.12: 6 residues within 4Å:- Chain A: L.216, L.219, G.220, L.223, R.224, L.227
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.223, A:R.224
- Salt bridges: A:R.224
OLA.13: 8 residues within 4Å:- Chain A: V.37, I.41, L.44, T.400, V.403, V.404, F.407
- Ligands: OLA.15
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.41, A:T.400, A:V.403, A:V.404
- Hydrogen bonds: A:V.403
OLA.14: 9 residues within 4Å:- Chain A: L.44, L.47, G.48, V.50, L.51, V.403, F.407, I.424, V.428
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.44, A:F.407, A:V.428
OLA.15: 15 residues within 4Å:- Chain A: P.27, G.30, S.31, V.33, Y.34, V.37, I.41, L.388, W.389, Y.392, L.393, V.396, T.400
- Ligands: OLA.11, OLA.13
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.33, A:V.37, A:Y.392, A:L.393
- Hydrogen bonds: A:Y.392
OLA.16: 6 residues within 4Å:- Chain A: G.148, A.151, I.152, V.155, L.156
- Ligands: OLC.22
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.152, A:I.152, A:I.152, A:L.156
OLA.17: 10 residues within 4Å:- Chain A: H.100, W.154, V.155, F.158, A.159, L.162, M.165, L.166
- Ligands: OLC.22, OLC.25
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.154, A:V.155, A:F.158, A:F.158, A:L.162, A:M.165, A:L.166
OLA.18: 3 residues within 4Å:- Ligands: OLA.5, OLA.7, OLA.8
No protein-ligand interaction detected (PLIP)OLA.19: 7 residues within 4Å:- Chain A: I.46, V.50, C.53, W.54, W.57, I.78
- Ligands: OLB.23
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:V.50, A:W.54, A:W.54, A:W.54, A:W.57, A:W.57, A:I.78
- Hydrogen bonds: A:W.57
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.20: 8 residues within 4Å:- Chain A: Y.204, F.208, L.212, V.213, L.216, F.378, F.379
- Ligands: OLC.24
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.208, A:F.208, A:F.208, A:L.212, A:V.213, A:L.216
- Hydrogen bonds: A:Y.204
OLC.21: 11 residues within 4Å:- Chain A: V.82, L.83, P.86, F.87, T.90, F.95, C.96, I.105
- Ligands: CLR.2, OLA.5, OLA.8
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.83, A:P.86, A:F.87, A:T.90, A:F.95, A:F.95
- Water bridges: A:C.96
OLC.22: 7 residues within 4Å:- Chain A: V.155, L.156, A.159, M.165, L.166
- Ligands: OLA.16, OLA.17
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.155, A:L.156, A:A.159, A:L.166
- Water bridges: A:H.100
OLC.24: 5 residues within 4Å:- Chain A: F.208, L.212, F.379
- Ligands: CLR.4, OLC.20
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.208, A:L.212, A:F.379
- Hydrogen bonds: A:F.379
OLC.25: 18 residues within 4Å:- Chain A: Y.68, V.71, S.72, A.75, A.76, A.79, L.83, F.87, F.104, F.108, L.112, K.147, I.150, W.154, F.158
- Ligands: CLR.2, OLA.17, OLB.23
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:A.79, A:F.104, A:F.108, A:F.108, A:L.112, A:W.154, A:W.154
- Hydrogen bonds: A:S.72, A:K.147
- 1 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Martynowycz, M.W. et al., A robust approach for MicroED sample preparation of lipidic cubic phase embedded membrane protein crystals. Nat Commun (2023)
- Release Date
- 2023-03-08
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON CRYSTALLOGRAPHY 2.00 Å
- Oligo State
- monomer
- Ligands
- 1 x ZMA: 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol(Non-covalent)
- 3 x CLR: CHOLESTEROL(Non-covalent)
- 15 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 1 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Martynowycz, M.W. et al., A robust approach for MicroED sample preparation of lipidic cubic phase embedded membrane protein crystals. Nat Commun (2023)
- Release Date
- 2023-03-08
- Peptides
- Adenosine receptor A2a,Soluble cytochrome b562: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.